This is the report from the first dialogue session, held in Washington, D.C. on June 10-11, 2014. From the Executive Summary: "Singapore is poised to be a critical partner to the US in minimizing biosecurity challenges in Southeast Asia. As a nation, it is vulnerable to both emerging infectious disease and potential terrorism in the region. In addition to its geographical importance within the Asia-Pacific region, Singapore is a rising powerhouse in biotechnology, having invested $13.2B in biotech R&D [Research and Development] from 2011-2015. As a result, it has become an attractive site for international biotechnology companies like Novartis, as well as world-class research universities. It is home to government and academic expertise capable of identifying and responding to biosecurity challenges. Its expertise is, in many ways, complementary to that of the US in these realms. For these reasons, the UPMC Center for Health Security hosted the first-ever Track II biosecurity dialogue between the United States and Singapore. The meeting took place in June 2014 in Washington, DC and was supported by the Project on Advanced Systems and Concepts for Countering WMD (PASCC), sponsored by the US Defense Threat Reduction Agency (DTRA)." Note: This document has been added to the Homeland Security Digital Library in agreement with the Project on Advanced Systems and Concepts for Countering WMD (PASCC) as part of the PASCC collection. Permission to download and/or retrieve this resource has been obtained through PASCC.
Public Domain. Downloaded or retrieved via external web link as part of the PASCC collection.
Singapore-US Strategic Dialogue on Biosecurity. Washington, D.C. June 10-11, 2014